Company appoints leading sales, market access and operations executives with decades of experience successfully launching and commercializing new oncology products
New Drug Application (NDA) for avasopasem is currently under priority review by the U.S. Food and Drug Administration (FDA) with a…
Source: www.marketscreener.com – Read more
News – Masimo reports cyber incident affecting production sites – teiss
Masimo has reported a cyber incident that has impacted its production sites. The company is currently assessing the situation to understand the extent of the
